2003
DOI: 10.1007/s11916-003-0024-2
|View full text |Cite
|
Sign up to set email alerts
|

Topical agents in the treatment of cluster headache

Abstract: This article discusses topical intranasal medications in the treatment of cluster headache.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
2

Year Published

2004
2004
2011
2011

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 28 publications
0
10
0
2
Order By: Relevance
“…Unlike migraine patients, patients with CH generally do not lie still during attacks and may pace with agitation and restlessness [11,12]. Acute CH medications include triptans, dihydroergotamine (DHE), inhaled oxygen, and intranasal lidocaine or capsacin [12][13][14][15]. Often CH occurs in cycles lasting weeks to months at a time with prolonged remissions.…”
Section: Cluster Headachementioning
confidence: 99%
“…Unlike migraine patients, patients with CH generally do not lie still during attacks and may pace with agitation and restlessness [11,12]. Acute CH medications include triptans, dihydroergotamine (DHE), inhaled oxygen, and intranasal lidocaine or capsacin [12][13][14][15]. Often CH occurs in cycles lasting weeks to months at a time with prolonged remissions.…”
Section: Cluster Headachementioning
confidence: 99%
“…"off-label use" verwendet werden, sind aber in der Kopfschmerztherapie unumgänglich [19]. Nebenwirkungsarm sind die intranasale Verabreichung von Lidocain [20,28] und die Insufflation von Sauerstoff. Die intranasale Verabreichung von Triptanen ist ebenfalls hilfreich [20,32], scheint jedoch der subkutanen Therapie in ihrer Wirksamkeit unterlegen.…”
Section: Therapieoptionenunclassified
“…The nasal application of lidocaine (1 ml with a concentration of 4-10% ipsilateral to the pain with the head reclined by 45°a nd rotated to the affected side by 30-40°) is effective in at least a third of the patients [56][57][58].…”
Section: Acute Therapymentioning
confidence: 99%